CLINICAL_TRIALS
trial_result
· 2021-06-08
Clinical Trial Update: Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults [Phase 1]
Summary
Phase 1 trial evaluating a malaria protein vaccine (FMP012) and PfCelTOS in malaria-naive adults has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2021-06-08